Traditional cardiac risk factors in individuals with chronic kidney disease

被引:75
作者
Uhlig, K [1 ]
Levey, AS [1 ]
Sarnak, MJ [1 ]
机构
[1] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA
关键词
D O I
10.1046/j.1525-139X.2003.16028.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Individuals with chronic kidney disease (CKD) are at increased risk for the development and progression of cardiovascular disease (CVD). The increased risk is due to a higher prevalence of both traditional risk factors as well as nontraditional risk factors. In this review we focus on individuals at all stages of CKD and discuss modifiable traditional risk factors, namely hypertension, dyslipidemia, diabetes mellitus and poor glycemic control, smoking, and physical inactivity. The prevalence of each risk factor and its relationship with CVD is described. Treatment recommendations are provided using evidence available from populations with CKD or evidence extrapolated from the general population when there are insufficient data on individuals with CKD.
引用
收藏
页码:118 / 127
页数:10
相关论文
共 122 条
[1]   Cardiovascular morbidity and risk factors in renal transplant patients [J].
Aakhus, S ;
Dahl, K ;
Wideroe, TE .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) :648-654
[2]   Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].
Adler, AI ;
Stratton, IM ;
Neil, HAW ;
Yudkin, JS ;
Matthews, DR ;
Cull, CA ;
Wright, AD ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419
[3]   Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].
Agodoa, LY ;
Appel, L ;
Bakris, GL ;
Beck, G ;
Bourgoignie, J ;
Briggs, JP ;
Charleston, J ;
Cheek, D ;
Cleveland, W ;
Douglas, JG ;
Douglas, M ;
Dowie, D ;
Faulkner, M ;
Gabriel, A ;
Gassman, J ;
Greene, T ;
Hall, Y ;
Hebert, L ;
Hiremath, L ;
Jamerson, K ;
Johnson, CJ ;
Kopple, J ;
Kusek, J ;
Lash, J ;
Lea, J ;
Lewis, JB ;
Lipkowitz, M ;
Massry, S ;
Middleton, J ;
Miller, ER ;
Norris, K ;
O'Connor, D ;
Ojo, A ;
Phillips, RA ;
Pogue, V ;
Rahman, M ;
Randall, OS ;
Rostand, S ;
Schulman, G ;
Smith, W ;
Thornley-Brown, D ;
Tisher, CC ;
Toto, RD ;
Wright, JT ;
Xu, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728
[4]   Treating tobacco use and dependence - An evidence-based clinical practice guideline for tobacco cessation [J].
Anderson, JE ;
Jorenby, DE ;
Scott, WJ ;
Fiore, MC .
CHEST, 2002, 121 (03) :932-941
[5]   AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].
ANDERSON, KM ;
WILSON, PWF ;
ODELL, PM ;
KANNEL, WB .
CIRCULATION, 1991, 83 (01) :356-362
[6]  
[Anonymous], 1996, JAMA, V276, P241
[7]  
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[8]  
[Anonymous], 1999, Drug Prescribing in Renal Failure
[9]   LOW-DOSE SIMVASTATIN IS A WELL-TOLERATED AND EFFICACIOUS CHOLESTEROL-LOWERING AGENT IN CYCLOSPORINE-TREATED KIDNEY-TRANSPLANT RECIPIENTS - DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY IN 40 PATIENTS [J].
ARNADOTTIR, M ;
ERIKSSON, LO ;
GERMERSHAUSEN, JI ;
THYSELL, H .
NEPHRON, 1994, 68 (01) :57-62
[10]   Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661